Quarantine Advice Update


Further to DrugAlert Volume 203, HPS Pharmacies wish to advise that AstraZeneca have recommended an extension of the temporary quarantine to include:

Bricanyl® Elixir


terbutaline sulfate 0.3mg/mL, 300mL

Aust R


Batch Nos.







This quarantine has been advised until the completion of an investigation into a manufacturing issue.

As a result of this manufacturing issue, AstraZeneca are experiencing an interruption to supply of Bricanyl® Elixir, and do not expect supplies to return to normal until 2015.

In the interim, as there is no generic equivalent product, HPS Pharmacies recommend using an alternative oral liquid bronchospasm relaxant, such as theophylline (Nuelin®) Syrup 26.67mg/5mL or salbutamol (Ventolin®) Sugar Free Syrup 2 mg/5mL.

This notice does not apply to terbutaline sulfate (Bricanyl®) injection ampoule 0.5mg/1mL or terbutaline sulfate (Bricanyl®) turbuhaler® 0.5mg/actuation.

Please inspect your stocks and quarantine all units from the above batches at your premises. Further advice will be issued when more information is known; at which time stock may be released for use or recalled.

This notice replaces DrugAlert Volume 203, and should be retained in a prominent position, including in other related business units as a reminder for all staff members until supply returns to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies, or AstraZeneca Medical Information on 1800 805 342.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates